- Report
- May 2024
- 140 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Aciphex (rabeprazole sodium) is a proton pump inhibitor (PPI) used to treat gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. It works by reducing the amount of acid produced in the stomach, which helps to relieve symptoms such as heartburn, difficulty swallowing, and persistent cough. Aciphex is also used to treat conditions such as erosive esophagitis, Zollinger-Ellison syndrome, and Helicobacter pylori infection.
Aciphex is part of a larger market of gastrointestinal drugs, which includes other PPIs such as Nexium, Prilosec, and Prevacid, as well as H2 blockers like Zantac and Pepcid. These drugs are used to treat a variety of gastrointestinal conditions, including GERD, peptic ulcers, and gastritis.
The companies in the Aciphex market include Eisai Co., Ltd., AstraZeneca, and Takeda Pharmaceuticals. Show Less Read more